Hidemi Nakagawa

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Richard G. Langley, Boni E. Elewski, Mark Lebwohl et al. · New England Journal of Medicine · 2014 · 2K citations · Full text

Medicine, Dermatology, Immunology +14

Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database

Kiyoshi Kubota, Yukari Kamijima, Tsugumichi Sato et al. · BMJ Open · 2015 · 308 citations · Full text

Public Health, Dermatology, Health Sciences +16

Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial

Kim Papp, Diamant Thaçi, Kristian Reich et al. · British Journal of Dermatology · 2015 · 268 citations · Full text

Medicine, Dermatology, Pharmacotherapy +16

Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

Hidemi Nakagawa, Osamu Nemoto, Atsuyuki Igarashi et al. · Journal of the American Academy of Dermatology · 2020 · 235 citations

Medicine, Dermatology, Pharmacology +15

Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families.

Tomoko Kawashima, Emiko Noguchi, Tadao Arinami et al. · Journal of Medical Genetics · 1998 · 212 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14